agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
2.200
-0.050 (-2.22%)
At close: Jul 15, 2025, 4:00 PM
2.200
0.00 (0.00%)
After-hours: Jul 15, 2025, 5:03 PM EDT
agilon health Stock Forecast
Stock Price Forecast
The 20 analysts that cover agilon health stock have a consensus rating of "Hold" and an average price target of $4.41, which forecasts a 100.45% increase in the stock price over the next year. The lowest target is $2 and the highest is $9.
Price Target: $4.41 (+100.45%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for agilon health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 2 | 3 | 3 | 3 |
Hold | 14 | 14 | 13 | 14 | 14 | 13 |
Sell | 2 | 2 | 2 | 2 | 2 | 2 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 18 | 18 | 19 | 21 | 21 | 20 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Evercore ISI Group | Evercore ISI Group | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +36.36% | Jul 9, 2025 |
Wells Fargo | Wells Fargo | Buy Maintains $6 → $5 | Buy | Maintains | $6 → $5 | +127.27% | May 13, 2025 |
Barclays | Barclays | Sell Maintains $2 → $3 | Sell | Maintains | $2 → $3 | +36.36% | May 8, 2025 |
Goldman Sachs | Goldman Sachs | Hold Maintains $2.5 → $5 | Hold | Maintains | $2.5 → $5 | +127.27% | May 8, 2025 |
JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 28, 2025 |
Financial Forecast
Revenue This Year
6.02B
from 6.06B
Decreased by -0.73%
Revenue Next Year
6.63B
from 6.02B
Increased by 10.12%
EPS This Year
-0.35
from -0.63
EPS Next Year
-0.26
from -0.35
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 6.3B | 7.6B | 9.3B | ||
Avg | 6.0B | 6.6B | 7.9B | ||
Low | 5.8B | 5.9B | 6.6B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.6% | 25.7% | 39.8% | ||
Avg | -0.7% | 10.1% | 19.8% | ||
Low | -4.7% | -2.1% | 0.3% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | -0.13 | -0.06 | 0.02 | |
Avg | -0.35 | -0.26 | -0.15 | |
Low | -0.44 | -0.39 | -0.27 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | - | - | - | |
Avg | - | - | - | |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.